Tamir Wolf, MD, PhD Joins the Cardiovascular Research Foundation as Senior Director, Operations and Development for the CRF Clinical Trials Center

New York, NY., The Cardiovascular Research Foundation (CRF) announced today that Tamir Wolf, MD, PhD has joined the organization as Senior Director, Operations and Development for the Clinical Trials Center (CTC), the academic research organization of CRF.  

Dr. Wolf will oversee the CTC’s business development and marketing activities, project management, and data administration. In collaboration with the CRF Skirball Center for Innovation, he will serve as the CTC lead on first in human (FIH) and early feasibility studies. In addition, he will lead new areas of economic analysis, big data, and health economics outcomes research. Dr. Wolf will also serve as a liaison to domestic and international startups and venture capital groups.   

“We are very excited to welcome Tamir to the CTC,” said Ori Ben-Yehuda, MD, Executive Director of the CRF Clinical Trials Center. “His background and experience in operations and business development will add to our ability to help bring innovative new technologies, therapies, and treatments to patients with cardiovascular disease.”   

“I am delighted to join the CRF Clinical Trials Center, an organization with a distinguished reputation for innovation and contributions to cardiovascular medicine and patient care,” said Dr. Wolf.  “I look forward to working with the CTC’s physicians and staff who are dedicated to advancing the field of interventional cardiovascular medicine,” said Dr. Wolf.    

Dr. Wolf brings a wealth of clinical and medical device development experience to CRF. He is a Co-Founder of Digma Medical and NiTiNOTES Surgical, medical device startups in Israel. Previously he was Medical Director for Accelmed, a leading investment firm in Israel, where he led investments and device development processes for numerous companies. Prior to that, Dr. Wolf was Vice President, Clinical Affairs at Sensible Medical Innovations. Earlier in his career, he was Director of Clinical Affairs at OmniGuide in Cambridge, Massachusetts, where he spearheaded clinical and market development for their neurosurgical line.    

Dr. Wolf received his MD and PhD at The Technion-Israel Institute of Technology in Haifa, and took part in the Executive Education program at Harvard Business School.   

About CRF and CTC

The Cardiovascular Research Foundation (CRF) is an independent, academically focused nonprofit organization dedicated to improving the survival and quality of life for people with heart disease through high quality research and education. Since its inception in 1991, CRF has played a major role in realizing dramatic improvements in the lives of countless numbers of patients by establishing the safe use of new technologies and therapies in interventional cardiovascular medicine.    

The CRF Clinical Trials Center (CTC) has shaped the cardiovascular field by directing some of the most influential and complex trials in recent decades. A distinguished academic research organization, the CTC specializes in trial design, imaging core labs, event adjudication, DSMBs, and biostatistical services. For over 20 years, the CTC has contributed to key advances in the treatment of cardiovascular disease and played an essential role in bringing innovative new technologies, pharmacologic therapies, and treatment paradigms to patients. For more information, please visit: http://www.crf.org/clinical-trials-center.   

Source: Cardiovascular Research Foundation